By this strategy, CTCs with positive ASGPR and CPS1 were detected in 29/32 (91%) of HCC patients, nevertheless, no CTCs were found in healthy volunteers, benign liver diseases and other cancer groups. This evidence concerns the gene ASGR1 and hepatocellular carcinoma.